bioRxiv Science⌕ Search

Biology subjects

Kuffner, K.

Publications and source records attributed to Kuffner, K..

2 recordsLinked to original sources

Induced neural progenitor cells and iPS-neurons from major depressive disorder patients show altered bioenergetics and electrophysiological properties

The molecular pathomechanisms of major depressive disorder (MDD) are still not completely understood. Here, we follow the hypothesis, that mitochondria dysfunction which is inevitably associated with bioenergetic disbalance is a risk factor that contributes to the susceptibility of an individual to develop MDD. Thus, we investigated molecular mechanisms related to mitochondrial function in induced neuronal progenitor cells (NPCs) which were reprogrammed from fibroblasts of eight MDD patients and eight non-depressed controls. We found significantly lower maximal respiration rates, altered cytosolic basal calcium levels, and smaller soma size in NPCs derived from MDD patients. These findings are partially consistent with our earlier observations in MDD patient-derived fibroblasts. Furthermore, we differentiated MDD and control NPCs into iPS-neurons and analysed their passive biophysical and active electrophysiological properties to investigate whether neuronal function can be related to altered mitochondrial activity and bioenergetics. Interestingly, MDD patient-derived iPS-neurons showed significantly lower membrane capacitance, a less hyperpolarized membrane potential, increased Na+ current density and increased spontaneous electrical activity. Our findings indicate that functional differences evident in fibroblasts derived from MDD patients are partially present after reprogramming to induced-NPCs, might relate to altered function of iPS-neurons and thus might be associated with the aetiology of major depressive disorder.

neuroscience↗

Chronic oxytocin-driven alternative splicing of CRFR2α induces anxiety

Recently, oxytocin (OXT) has generated considerable interest as potential treatment for psychiatric disorders, including general anxiety disorder or autism spectrum disorder. Therefore, knowledge on the involved molecular processes downstream of OXT receptor (OXTR) activation is indispensable. We reveal that alternative splicing of corticotropin releasing factor receptor 2 (CRFR2) parallels increased anxiety-like behavior following chronic OXT treatment, contrasting the well-known anxiolysis of acute OXT. In detail, chronic OXT shifts the splicing ratio between membrane-bound (mCRFR2) and soluble CRFR2 (sCRFR2) in favor of the latter via ERK1/2-MEF2A signaling. Targeted manipulations of Crfr2 splicing mimic the effect of chronic OXT, confirming its role in the regulation of anxiety-like behavior. Furthermore, chronic OXT triggers cytoplasmic distribution and extracellular release of sCRFR2 into the cerebrospinal fluid, with sCRFR2 levels positively correlating with anxiety-like behavior. Concluding, the dichotomy between anxiolytic mCRFR2 and anxiogenic sCRFR2 is the basis for the deleterious effects of chronic OXT on anxiety. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/255844v1_ufig1.gif" ALT="Figure 1"> View larger version (51K): org.highwire.dtl.DTLVardef@1b50691org.highwire.dtl.DTLVardef@1c22efborg.highwire.dtl.DTLVardef@19a772eorg.highwire.dtl.DTLVardef@69af7_HPS_FORMAT_FIGEXP M_FIG C_FIG

animal behavior and cognition↗